Literature DB >> 26096847

Evaluation of delivered dose for a clinical daily adaptive plan selection strategy for bladder cancer radiotherapy.

Lotte J Lutkenhaus1, Jorrit Visser2, Rianne de Jong2, Maarten C C M Hulshof2, Arjan Bel2.   

Abstract

PURPOSE: To account for variable bladder size during bladder cancer radiotherapy, a daily plan selection strategy was implemented. The aim of this study was to calculate the actually delivered dose using an adaptive strategy, compared to a non-adaptive approach.
MATERIAL AND METHODS: Ten patients were treated to the bladder and lymph nodes with an adaptive full bladder strategy. Interpolated delineations of bladder and tumor on a full and empty bladder CT scan resulted in five PTVs for which VMAT plans were created. Daily cone beam CT (CBCT) scans were used for plan selection. Bowel, rectum and target volumes were delineated on these CBCTs, and delivered dose for these was calculated using both the adaptive plan, and a non-adaptive plan.
RESULTS: Target coverage for lymph nodes improved using an adaptive strategy. The full bladder strategy spared the healthy part of the bladder from a high dose. Average bowel cavity V30Gy and V40Gy significantly reduced with 60 and 69ml, respectively (p<0.01). Other parameters for bowel and rectum remained unchanged.
CONCLUSIONS: Daily plan selection compared to a non-adaptive strategy yielded similar bladder coverage and improved coverage for lymph nodes, with a significant reduction in bowel cavity V30Gy and V40Gy only, while other sparing was limited.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive radiotherapy; Bladder cancer; Normal tissue sparing; Plan of the day; Plan selection

Mesh:

Year:  2015        PMID: 26096847     DOI: 10.1016/j.radonc.2015.06.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Deep learning driven predictive treatment planning for adaptive radiotherapy of lung cancer.

Authors:  Donghoon Lee; Yu-Chi Hu; Licheng Kuo; Sadegh Alam; Ellen Yorke; Anyi Li; Andreas Rimner; Pengpeng Zhang
Journal:  Radiother Oncol       Date:  2022-02-18       Impact factor: 6.901

2.  Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes.

Authors:  Jenny Bertholet; Gail Anastasi; David Noble; Arjan Bel; Ruud van Leeuwen; Toon Roggen; Michael Duchateau; Sara Pilskog; Cristina Garibaldi; Nina Tilly; Rafael García-Mollá; Jorge Bonaque; Uwe Oelfke; Marianne C Aznar; Ben Heijmen
Journal:  Radiother Oncol       Date:  2020-06-21       Impact factor: 6.280

3.  Comparison of Library of Plans with two daily adaptive strategies for whole bladder radiotherapy.

Authors:  Duncan den Boer; Mariska D den Hartogh; Alexis N T J Kotte; Jochem R N van der Voort van Zyp; Juus L Noteboom; Gijsbert H Bol; Thomas Willigenburg; Anita M Werensteijn-Honingh; Ina M Jürgenliemk-Schulz; Astrid L H M W van Lier; Petra S Kroon
Journal:  Phys Imaging Radiat Oncol       Date:  2021-11-20

4.  Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.

Authors:  Lotte J Lutkenhaus; Rob M van Os; Arjan Bel; Maarten C C M Hulshof
Journal:  Radiat Oncol       Date:  2016-03-18       Impact factor: 3.481

5.  Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer.

Authors:  Yingqiu Song; Beth Erickson; Xiaojian Chen; Guiling Li; Gang Wu; Eric Paulson; Paul Knechtges; X Allen Li
Journal:  Oncotarget       Date:  2018-01-06

6.  Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer.

Authors:  Andrew Kochan; Ryan Rivest; Katie Galloway; Pascal Lambert; Aldrich Ong; Rashmi Koul; Shahida Ahmed; Bashir Bashir; Harvey Quon
Journal:  Cureus       Date:  2017-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.